Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 394,111 | 340,750 | 327,868 | 287,458 | 275,706 |
| Cost of Goods | 64,326 | 54,718 | 58,828 | 55,135 | 48,742 |
| Gross Profit | 329,785 | 286,032 | 269,040 | 232,323 | 226,964 |
| Operating Expenses | 306,215 | 293,200 | 285,300 | 266,485 | 251,333 |
| Operating Income | 23,896 | -6,450 | -15,432 | -34,027 | -23,627 |
| Interest Expense | 0 | 0 | 0 | 498 | 764 |
| Other Income | 3,028 | 4,097 | 2,894 | 221 | 192 |
| Pre-tax Income | 26,924 | -2,353 | -12,538 | -34,304 | -24,199 |
| Income Tax | 1,247 | 1,504 | 1,381 | -996 | 393 |
| Net Income Continuous | 25,677 | -3,857 | -13,919 | -33,308 | -24,592 |
| Net Income | $25,677 | $-3,857 | $-13,919 | $-33,308 | $-24,592 |
| EPS Basic Total Ops | 0.72 | -0.11 | -0.42 | -1.03 | -0.78 |
| EPS Basic Continuous Ops | 0.72 | -0.11 | -0.42 | -1.03 | -0.78 |
| EPS Diluted Total Ops | 0.68 | -0.11 | -0.42 | -1.03 | -0.78 |
| EPS Diluted Continuous Ops | 0.68 | -0.11 | -0.42 | -1.03 | -0.78 |
| EPS Diluted Before Non-Recurring Items | 1.05 | 0.01 | -0.42 | -1.04 | -0.78 |
| EBITDA(a) | $36,565 | $5,309 | $-6,499 | $-26,958 | $-16,757 |